GTG's

GTG became involved with this project in early 2001, when preliminary studies on immunodeficiency linked to retroviral infection, such as AIDS, at the University of Western Australia, produced results described at the time as "quite remarkable". A new company, Immunaid Pty Limited was formed in March, 2001, to acquire this project. GTG owns 60% of... Immunaid, with the other 40% held by the scientist who developed the original concepts and by the researchers now working on the project. A first patent was filed on August 16th, 2001, with Martin Ashdown as inventor and Immunaid as assignee. A Technical Review Committee has been established to oversee the scientific activity and direction of GTG's Immunaid project. This Technical Review Committee comprised: (i) Associate Professor Nicholas J. Deacon, Head of AIDS Molecular Biology Unit, National Centre in HIV Virology Research, (ii) Professor James McCluskey, Head of the Department of Microbiology & Immunology, University of Melbourne, (iii) Associate Professor Steven Kent, Infectious Disease Physician, Alfred Hospital, Melbourne, (iv) Dr. Manfred Bielharz, Deputy Head, Department of Microbiology, University of Western Australia, (v) Dr. George Rudy, Scientific Director of the GTG's Melbourne subsidiary, GeneType, (vi) Mr. Martin Ashdown, B.Sc, the inventor, (vii) Ms. Luisa Ashdown M.Sc, a senior scientist at GeneType, and (viii) Dr. Mervyn Jacobson, Executive Chairman of GTG, who also chairs the Technical Review Committee. GTG is pleased to report that Associate Professor Martyn French, Head, Communicable Diseases Service, Royal Perth Hospital has also just joined the Immunaid Technical Review Committee. The Immunaid Technical Review Committee met on June 21st and reviewed the progress and results achieved by the Immunaid research team in relation to various mouse models. The Committee has now urged GTG to expand this research. In particular, certain encouraging research results achieved in mice should now be repeated in a higher species - possibly cats. In ...Read More